Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surface Plasmon Resonance | 6 | 2024 | 87 | 1.280 |
Why?
|
| Liver Neoplasms | 6 | 2026 | 776 | 0.680 |
Why?
|
| Myofibromatosis | 1 | 2019 | 10 | 0.600 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 117 | 0.550 |
Why?
|
| Medical Oncology | 3 | 2024 | 339 | 0.470 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2025 | 372 | 0.470 |
Why?
|
| Hepatoblastoma | 2 | 2026 | 52 | 0.400 |
Why?
|
| Diagnostic Imaging | 6 | 2024 | 337 | 0.350 |
Why?
|
| Liver Diseases | 2 | 2025 | 305 | 0.350 |
Why?
|
| Neoplasms | 1 | 2023 | 2906 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2026 | 3904 | 0.230 |
Why?
|
| Spermatids | 2 | 2016 | 25 | 0.220 |
Why?
|
| Contrast Media | 5 | 2026 | 497 | 0.210 |
Why?
|
| Microfilament Proteins | 2 | 2016 | 135 | 0.210 |
Why?
|
| End Stage Liver Disease | 1 | 2025 | 95 | 0.200 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2023 | 11 | 0.200 |
Why?
|
| Craniosynostoses | 1 | 2024 | 69 | 0.200 |
Why?
|
| Child | 13 | 2026 | 22707 | 0.200 |
Why?
|
| Ultrasonography | 2 | 2024 | 785 | 0.190 |
Why?
|
| Abdominal Neoplasms | 1 | 2023 | 47 | 0.190 |
Why?
|
| Cartilage | 1 | 2024 | 197 | 0.190 |
Why?
|
| Rhabdomyoma | 1 | 2022 | 7 | 0.190 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2022 | 38 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 81 | 0.180 |
Why?
|
| Trachea | 1 | 2024 | 258 | 0.180 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2023 | 73 | 0.180 |
Why?
|
| Heart Neoplasms | 1 | 2022 | 56 | 0.180 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 56 | 0.180 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2023 | 131 | 0.170 |
Why?
|
| Fatty Liver | 1 | 2023 | 253 | 0.160 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2019 | 161 | 0.140 |
Why?
|
| Radiopharmaceuticals | 1 | 2019 | 205 | 0.140 |
Why?
|
| Liver Transplantation | 1 | 2025 | 826 | 0.140 |
Why?
|
| Infant | 5 | 2026 | 10077 | 0.130 |
Why?
|
| Pediatrics | 1 | 2025 | 1121 | 0.130 |
Why?
|
| Actins | 2 | 2016 | 425 | 0.120 |
Why?
|
| Fetal Proteins | 1 | 2016 | 15 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 712 | 0.120 |
Why?
|
| Spermatogenesis | 1 | 2016 | 91 | 0.120 |
Why?
|
| Testis | 1 | 2016 | 162 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2026 | 2769 | 0.110 |
Why?
|
| Humans | 18 | 2026 | 145474 | 0.110 |
Why?
|
| Microtubules | 1 | 2016 | 265 | 0.100 |
Why?
|
| Child, Preschool | 5 | 2026 | 11853 | 0.090 |
Why?
|
| Androgens | 1 | 2014 | 181 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 740 | 0.080 |
Why?
|
| Testosterone | 1 | 2014 | 416 | 0.080 |
Why?
|
| Male | 6 | 2026 | 72842 | 0.050 |
Why?
|
| Syndrome | 1 | 2024 | 381 | 0.050 |
Why?
|
| Cystography | 1 | 2022 | 2 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2024 | 142 | 0.050 |
Why?
|
| Urination | 1 | 2022 | 47 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 2187 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2025 | 1508 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 287 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 899 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1149 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 3413 | 0.030 |
Why?
|
| Sertoli Cells | 1 | 2016 | 28 | 0.030 |
Why?
|
| Female | 4 | 2026 | 78844 | 0.030 |
Why?
|
| Tubulin | 1 | 2016 | 146 | 0.030 |
Why?
|
| Sperm Transport | 1 | 2014 | 2 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 1896 | 0.030 |
Why?
|
| Placebos | 1 | 2014 | 193 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 6013 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 107 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 204 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2025 | 2970 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 959 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 2524 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 855 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 2028 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 4148 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 5584 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 22529 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2014 | 1244 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 38030 | 0.010 |
Why?
|
| Inflammation | 1 | 2014 | 2878 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 4295 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 5216 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 10885 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 14218 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 36215 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 40777 | 0.000 |
Why?
|